Extension of Time to File SOU

SKYSTAR

Skyhawk Therapeutics, Inc.

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88119367
LAW OFFICE ASSIGNED LAW OFFICE 110
MARK SECTION
MARK SKYSTAR (see, http://uspto.report/TM/88119367/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT SKYSTAR
OWNER SECTION (current)
NAME Skyhawk Therapeutics, Inc.
MAILING ADDRESS 35 Gatehouse Drive
CITY Waltham
STATE Massachusetts
ZIP/POSTAL CODE 02451
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
OWNER SECTION (proposed)
NAME Skyhawk Therapeutics, Inc.
MAILING ADDRESS 35 Gatehouse Drive
CITY Waltham
STATE Massachusetts
ZIP/POSTAL CODE 02451
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Peter Kunin
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE tmip@drm.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
CORRESPONDENCE INFORMATION (proposed)
NAME Peter Kunin
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE tmip@drm.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
DOCKET/REFERENCE NUMBER 16694005UST1
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression, used in the treatment of cancers, neurological diseases, and other diseases
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 4
ONGOING EFFORT product or service research or development
ALLOWANCE MAIL DATE 04/02/2019
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /Peter Kunin/
SIGNATORY'S NAME Peter Kunin
SIGNATORY'S POSITION Attorney of record, VT bar member
DATE SIGNED 03/17/2021
SIGNATORY'S PHONE NUMBER 802-846-8342
SIGNATURE METHOD Sent to third party for signature
FILING INFORMATION
SUBMIT DATE Thu Mar 18 09:05:53 ET 2021
TEAS STAMP USPTO/ESU-XXX.XX.XXX.XX-2
0210318090553912225-88119
367-7708dc94f6b5a5f5e9956
823b7786a678e1582ef469dce
3c4167536aac36ae1d73-CC-0
5501358-20210317152150429
212



PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: SKYSTAR (see, http://uspto.report/TM/88119367/mark.png)
SERIAL NUMBER: 88119367

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Skyhawk Therapeutics, Inc., having an address of
      35 Gatehouse Drive
      Waltham, Massachusetts 02451
      United States
      Email: XXXX
Proposed: Skyhawk Therapeutics, Inc., having an address of
      35 Gatehouse Drive
      Waltham, Massachusetts 02451
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 04/02/2019.

For International Class 005:
Current identification: Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression, used in the treatment of cancers, neurological diseases, and other diseases

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the fourth extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development

Correspondence Information (current):
      Peter Kunin
      PRIMARY EMAIL FOR CORRESPONDENCE: tmip@drm.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED

Correspondence Information (proposed):
      Peter Kunin
      PRIMARY EMAIL FOR CORRESPONDENCE: tmip@drm.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Peter Kunin/      Date Signed: 03/17/2021
Signatory's Name: Peter Kunin
Signatory's Position: Attorney of record, VT bar member
Signatory's Phone: 802-846-8342
Signature method: Sent to third party for signature

PAYMENT: 88119367
PAYMENT DATE: 03/18/2021

Serial Number: 88119367
Internet Transmission Date: Thu Mar 18 09:05:53 ET 2021
TEAS Stamp: USPTO/ESU-XXX.XX.XXX.XX-2021031809055391
2225-88119367-7708dc94f6b5a5f5e9956823b7
786a678e1582ef469dce3c4167536aac36ae1d73
-CC-05501358-20210317152150429212




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed